# Pentoxifylline in Patients With Nonalcoholic Steatohepatitis

> **NCT00590161** · PHASE2 · COMPLETED · sponsor: **Case Western Reserve University** · enrollment: 55 (actual)

## Conditions studied

- Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** pentoxifylline (PTX)
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00590161
- **Lead sponsor:** Case Western Reserve University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2013-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590161

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590161, "Pentoxifylline in Patients With Nonalcoholic Steatohepatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00590161. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*